VISEN PHARMA-B 02561·

Gross margin --------------------11.52%-- Net margin ---------------------153589.09%-- ROE -----57.17%---44.28%12.89%-63.85%19.57%-75.53%11.68%-33.26%42.28% ROA -----52.10%---38.98%13.12%-56.24%17.25%-62.02%5.79%-25.93%36.09% Attributable profit growth --------40.39%--13.63%26.76%26.98%13.34%-39.06%66.04% Debt-to-assets ----8.86%--11.96%3.11%11.92%0.04%17.88%5.96%22.02%4.14% Current ratio ----11.79--8.153.657.220.934.262.954.470.20 Operating cash flow / net profit ----0.47--0.850.391.090.230.770.311.770.99 Operating cash flow / revenue ---------------------271262.42%--

Gross margin ----52.29%-- Net margin -----301.38%-- Attributable profit growth ----11.79%-- Debt-to-assets ----24.34%-- Current ratio ----4.00-- Operating cash flow / net profit 0.92--1.150.22 Operating cash flow / revenue -----345.09%--

Revenue --------------------165.00K-- Other income and gains ----1.25M--5.76M360.75%11.36M97.02%9.86M13.14%11.94M21.06% Gross profit --------------------19.00K-- Selling and distribution expenses --------------------31.19M-- Administrative expenses ----174.35M--177.45M1.78%79.94M54.95%86.43M8.12%115.14M33.21% Net finance costs ----734.00K--619.00K15.67%317.00K48.79%161.00K49.21%1.10M581.99% Operating profit -----468.90M---288.35M38.51%-249.25M13.56%-182.08M26.95%-252.32M38.58% Profit before tax -----484.78M---288.97M40.39%-249.57M13.63%-182.24M26.98%-253.42M39.06% Net profit -----484.78M---288.97M40.39%-249.57M13.63%-182.24M26.98%-253.42M39.06% Net profit attributable to owners -----484.78M---288.97M40.39%-249.57M13.63%-182.24M26.98%-253.42M39.06%

Revenue 0--34.54M-- Other income and gains 5.30M--5.04M5.00% Cost of sales 0--16.48M-- Gross profit 0--18.06M-- Selling and distribution expenses 0--35.77M-- Administrative expenses 60.05M--33.60M44.04% Net finance costs 39.00K--2.03M5110.26% Income tax 0--0-- Profit before tax -118.02M---104.10M11.79% Net profit -118.02M---104.10M11.79% Net profit attributable to owners -118.02M---104.10M11.79%

Cash and cash equivalents ----882.65M--626.46M29.03%347.78M44.48%203.59M41.46%632.64M210.75% Trade and bills receivables --------------------165.00K-- Inventories --------------------1.53M-- Total current assets ----895.07M--711.59M20.50%374.12M47.42%222.57M40.51%942.05M323.25% Total assets ----930.39M--741.27M20.33%443.80M40.13%293.82M33.79%977.30M232.61% Total current liabilities ----75.90M--87.34M15.08%51.82M40.66%52.19M0.70%210.96M304.22% Total liabilities ----82.39M--88.67M7.61%52.92M40.31%52.55M0.70%215.24M309.61% Equity attributable to owners ----848.00M--652.61M23.04%390.88M40.11%241.28M38.27%762.05M215.84% Total equity ----848.00M--652.61M23.04%390.88M40.11%241.28M38.27%762.05M215.84%

Cash and cash equivalents ----505.81M-- Trade and bills receivables ----34.90M-- Inventories ----55.95M-- Total current assets ----849.44M-- Total assets ----887.16M-- Total current liabilities ----212.17M-- Total liabilities ----215.91M-- Equity attributable to owners ----671.25M-- Total equity ----671.25M--

Net cash from operating activities -----226.48M---246.55M8.86%-271.31M10.04%-140.86M48.08%-447.58M217.75% Net cash from investing activities -----13.59M---1.77M87.00%-520.00K70.55%-117.00K77.50%6.67M5798.29% Net cash from financing activities ----964.80M---7.95M100.82%-6.95M12.54%-3.09M55.57%870.00M28264.42% Net change in cash ----724.74M---256.26M135.36%-278.78M8.79%-144.06M48.32%429.08M397.84%

Net cash from operating activities -108.69M---119.20M9.67% Net cash from investing activities 9.24M---559.00K106.05% Net cash from financing activities 701.64M---6.84M100.97% Net change in cash 602.19M---126.60M121.02%